H. E. Scholtz

713 total citations
10 papers, 419 citations indexed

About

H. E. Scholtz is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Analytical Chemistry. According to data from OpenAlex, H. E. Scholtz has authored 10 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Surgery and 2 papers in Analytical Chemistry. Recurrent topics in H. E. Scholtz's work include Diabetes Management and Research (6 papers), Diabetes Treatment and Management (4 papers) and Pancreatic function and diabetes (4 papers). H. E. Scholtz is often cited by papers focused on Diabetes Management and Research (6 papers), Diabetes Treatment and Management (4 papers) and Pancreatic function and diabetes (4 papers). H. E. Scholtz collaborates with scholars based in South Africa, United States and United Kingdom. H. E. Scholtz's co-authors include R. H. A. Becker, D. H. Wessels, Annke Frick, Maria Potgieter, F J Burger, Claudio Perret, B. Lenfant, Guy Montay, Robert Schall and W.F. Mollentze and has published in prestigious journals such as Diabetologia, British Journal of Clinical Pharmacology and European Journal of Clinical Pharmacology.

In The Last Decade

H. E. Scholtz

10 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. E. Scholtz South Africa	9	306	216	101	92	31	10	419
Chuqing Cao China	10	237 0.8×	129 0.6×	120 1.2×	118 1.3×	63 2.0×	14	419
Sabine Arnolds Germany	14	707 2.3×	431 2.0×	266 2.6×	86 0.9×	11 0.4×	28	765
Grit Andersen Germany	8	227 0.7×	131 0.6×	51 0.5×	75 0.8×	115 3.7×	21	335
Simon E. Regnell Sweden	7	208 0.7×	171 0.8×	173 1.7×	43 0.5×	106 3.4×	8	365
Yoshimichi Takeda Japan	11	152 0.5×	84 0.4×	17 0.2×	78 0.8×	34 1.1×	30	301
Daniel A. Nadeau United States	9	175 0.6×	95 0.4×	61 0.6×	79 0.9×	4 0.1×	13	318
Jasna Klen Slovenia	10	131 0.4×	80 0.4×	23 0.2×	103 1.1×	23 0.7×	21	250
Saleem Ullah Shahid Pakistan	13	88 0.3×	89 0.4×	96 1.0×	149 1.6×	91 2.9×	26	404
Olivier Scruel France	11	141 0.5×	142 0.7×	18 0.2×	82 0.9×	38 1.2×	20	311
Yongwei Jiang China	12	77 0.3×	77 0.4×	31 0.3×	93 1.0×	52 1.7×	33	337

Countries citing papers authored by H. E. Scholtz

Since Specialization

Citations

This map shows the geographic impact of H. E. Scholtz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. E. Scholtz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. E. Scholtz more than expected).

Fields of papers citing papers by H. E. Scholtz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. E. Scholtz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. E. Scholtz. The network helps show where H. E. Scholtz may publish in the future.

Co-authorship network of co-authors of H. E. Scholtz

This figure shows the co-authorship network connecting the top 25 collaborators of H. E. Scholtz. A scholar is included among the top collaborators of H. E. Scholtz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. E. Scholtz. H. E. Scholtz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Becker, R. H. A., et al.. (2005). A Comparison of the Steady-State Pharmacokinetics and Pharmacodynamics of a Novel Rapid-Acting Insulin Analog, Insulin Glulisine, and Regular Human Insulin in Healthy Volunteers Using the Euglycemic Clamp Technique. Experimental and Clinical Endocrinology & Diabetes. 113(5). 292–297. 34 indexed citations

Becker, R. H. A., et al.. (2005). Insulin Glulisine, a New Rapid-Acting Insulin Analogue, Displays a Rapid Time-Action Profile in Obese Non-Diabetic Subjects. Experimental and Clinical Endocrinology & Diabetes. 113(8). 435–443. 73 indexed citations

Scholtz, H. E., et al.. (2005). Pharmacokinetic and glucodynamic variability: assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique. Diabetologia. 48(10). 1988–1995. 92 indexed citations

Scholtz, H. E., et al.. (2003). Equipotency of insulin glargine and regular human insulin on glucose disposal in healthy subjects following intravenous infusion. Acta Diabetologica. 40(4). 156–162. 20 indexed citations

Herz, Matthias, Vipin Arora, Barbara N. Campaigne, et al.. (2003). Humalog Mix25 improves 24-hour plasma glucose profiles compared with the human insulin mixture 30/70 in patients with type 2 diabetes mellitus.. PubMed. 93(3). 219–23. 17 indexed citations

Scholtz, H. E., et al.. (2003). Biotransformation of insulin glargine after subcutaneous injection in healthy subjects. Current Medical Research and Opinion. 19(1). 34–40. 101 indexed citations

Perret, Claudio, et al.. (2002). Pharmacokinetics and Absolute Oral Bioavailability of an 800-mg Oral Dose of Telithromycin in Healthy Young and Elderly Volunteers. Chemotherapy. 48(5). 217–223. 43 indexed citations

Scholtz, H. E., et al.. (1995). The effect of fasting on total serum bilirubin concentrations.. British Journal of Clinical Pharmacology. 39(2). 169–171. 25 indexed citations

Scholtz, H. E., F. O. Müller, H. G. Luus, et al.. (1994). Lack of interaction between ramipril and simvastatin. European Journal of Clinical Pharmacology. 47(4). 373–375. 12 indexed citations

10.

Pavlick, Ryan, et al.. (1980). Analytical problem solving with verification samples interference reduction options. Journal of Environmental Science and Health Part A Environmental Science and Engineering. 15(5). 513–523. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact